Eledon Pharmaceuticals Inc
Eledon Pharmaceuticals Inc (ELDN) Options Open Interest
ELDN options open interest is 9,988 contracts. The 2-week average daily volume is 183 contracts across the chain.
Read more
Monitoring ELDN open interest helps you see where real money is positioned on Eledon Pharmaceuticals Inc's options and which strikes are attracting the most commitment from traders. Eledon Pharmaceuticals Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ELDN options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ELDN options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Eledon Pharmaceuticals Inc to settle.
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc.
and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ELDN open interest is concentrated. Our scanner maps Eledon Pharmaceuticals Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Eledon Pharmaceuticals Inc's options open interest as the signal it is, not as an afterthought.
| 5.00 | — | 1.00 | 1.00 | 543% | +0.6062 | 228 |
| 2.50 | — | 0.95 | 0.95 | 325% | +0.6958 | 59 |
| 7.50 | — | 1.00 | 1.00 | 631% | +0.5786 | 0 |
| 2.50 | — | 0.30 | 0.30 | 146% | -0.3483 | 0 |
| 5.00 | 2.00 | 3.00 | 2.50 | 247% | -0.7395 | 0 |
| 7.50 | 4.40 | 5.40 | 4.90 | 278% | -0.8536 | 0 |
As of September 21, 2026
Follow the money
Track ELDN open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→